Show simple item record

dc.contributor.authorStrøm, Hanne
dc.contributor.authorSelmer, Randi
dc.contributor.authorBirkeland, Kåre I.
dc.contributor.authorSchirmer, Henrik
dc.contributor.authorBerg, Tore Julsrud
dc.contributor.authorJenum, Anne Karen
dc.contributor.authorMidthjell, Kristian
dc.contributor.authorBerg, Christian
dc.contributor.authorStene, Lars Christian
dc.date.accessioned2014-08-14T12:37:56Z
dc.date.available2014-08-14T12:37:56Z
dc.date.issued2014
dc.description.abstractBackground: National estimates for the occurrence of diabetes are difficult to obtain, particularly time trends in incidence. The aim was to describe time trends in prevalent and incident use of blood glucose-lowering drugs by age group and gender in Norway during 2005–2011. Methods: Data were obtained from the nationwide Norwegian Prescription Database. We defined prevalent users of “insulins only” as individuals having no oral antidiabetic drugs (OAD) dispensed from a pharmacy during the previous 24 months or in the subsequent 12 months. Incident users had no blood glucose-lowering drugs dispensed in the previous 24 months; incident “insulins only” users also had no OAD in the subsequent 12 months. Results: In 2011, 3.2% of the population had blood glucose-lowering drugs dispensed, and the incidence rate was 313 per 100,000 person years. The prevalence of OAD use increased from 1.8% in 2005 to 2.4% in 2011; however a decreasing trend in incidence of OAD use was observed, particularly in those aged 70 years and older. In 2010, 0.64% of the population had insulins only dispensed, with an overall incidence rate in the total population of 33 per 100,000 person years which was stable over time. Conclusions: In this nationwide study, we found that although the prevalent use of OAD had increased in recent years, incident use was stable or had decreased. This may indicate that the increase in diabetes occurrence in Norway is levelling off, at least temporarily.en
dc.identifier.citationBMC Public Health (2014), vol.14:520en
dc.identifier.cristinIDFRIDAID 1139958
dc.identifier.doihttp://dx.doi.org/10.1186/1471-2458-14-520
dc.identifier.issn1471-2458
dc.identifier.urihttps://hdl.handle.net/10037/6524
dc.identifier.urnURN:NBN:no-uit_munin_6125
dc.language.isoengen
dc.publisherBioMed Centralen
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Clinical pharmacology: 739en
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Klinisk farmakologi: 739en
dc.titleNo increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database studyen
dc.typeJournal articleen
dc.typeTidsskriftartikkelen
dc.typePeer revieweden


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record